Metraipolis › archive › dc_f021e031980a
γ-Oryzanol-Loaded PLGA nanoparticles: enhanced drug delivery and therapeutic efficacy for breast cancer therapy — Europe PMC PMID:40969227
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40969227
- DOI
- 10.3389/fbioe.2025.1675338
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T03:48:05.968Z
- SHA-256 of the archived text
033c2d3a499906d4b33a98db1f4bb3c805016ce3a0c1634f7ccbbcd9d4ddadd0- Stable URL of this page
https://metraipolis.com/documento/dc_f021e031980a
How to cite
γ-Oryzanol-Loaded PLGA nanoparticles: enhanced drug delivery and therapeutic efficacy for breast cancer therapy — Europe PMC PMID:40969227 — Europe PMC (en), https://europepmc.org/article/MED/40969227 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f021e031980a (Metraipolis archive dc_f021e031980a, sha256 033c2d3a499906d4b33a98db1f4bb3c805016ce3a0c1634f7ccbbcd9d4ddadd0)
BibTeX
@misc{dcf021e031980a,
title = {γ-Oryzanol-Loaded PLGA nanoparticles: enhanced drug delivery and therapeutic efficacy for breast cancer therapy — Europe PMC PMID:40969227},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40969227},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f021e031980a; sha256 033c2d3a499906d4b33a98db1f4bb3c805016ce3a0c1634f7ccbbcd9d4ddadd0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40969227. Agents can read the archived copy with the MCP tool read_document.